OpenBilldrug price receipt

NADAC week of 2026-10-14

FENTANYL 2,500 MCG/50 ML VIAL

For 50 mL

Pharmacies pay

$89.32 filed

50 × $1.78639 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part B pays

$34.05 derived

50 × $0.681 per ML, Part B limit

Medicare's price is not your price.

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)


The spread

0.38× estimated

Medicare pays 62% less than pharmacies pay.

5 labelers share HCPCS J3010 on the CMS crosswalk, so its payment limit is an average across all their products billed under that code, not this NDC’s own price.

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Cost-plus estimate

$107.72 estimated

$89.32 + $13.40 (15%) + $5.00 fee per fill = $107.72

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

FENTANYL 2,500 MCG/50 ML VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as fentanyl citrate.

FDA gives its dosage form as “injection, solution” and “injection” and its route as “intramuscular; intravenous” and “intravenous”.

FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Hospira, Inc., Hikma Pharmaceuticals USA Inc. and Fresenius Kabi USA, LLC.

FDA’s Established Pharmacologic Class for it is Opioid Agonist.

The NADAC file of 2026-10-14 prices it under 6 NDCs (National Drug Codes); the FDA directory lists 4 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $89.32 for 50 mL (50 × $1.78639 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-10-07. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

All 6 NDCs

Other strengths, forms and brands

2 other products in the NADAC file share the FDA nonproprietary name fentanyl citrate with FENTANYL 2,500 MCG/50 ML VIAL.

ProductPharmacies pay per unitMedicare per unit
FENTANYL 2,500 MCG/50 ML VIAL this page
generic · injection, solution / injection
$1.78639 per ML filed
eff. 2026-09-23 to 2026-10-07
$0.681 per ML derived
Part B limit 2026 Q4
FENTANYL 100 MCG/2 ML VIAL
generic · injection, solution / injection
$1.78639 per ML filed
eff. 2026-09-23
$0.681 per ML derived
Part B limit 2026 Q4
FENTANYL 250 MCG/5 ML VIAL
generic · injection
$1.78639 per ML filed
eff. 2026-09-23
$0.681 per ML derived
Part B limit 2026 Q4

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Compared with its class

The middle of its 6 NDCs’ NADAC prices is $1.78639 per ML filed.

Of the 31 other products in FDA’s Opioid Agonist class priced per ML, 9 have a higher middle NADAC price and 20 a lower one; 2 have the same. The one in the middle is MORPHINE SULF 100 MG/5 ML CONC, at $0.39203 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part B’s payment limit for HCPCS J3010, for 2026-10-01 to 2026-12-31, comes to $34.05 for 50 mL, or $0.681 per ML once converted to NADAC’s unit for this product.

Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.2724 per 0.1 MG.

3 of the product’s 6 NDCs have this Medicare figure; the other 3 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 50 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 50 mL in one package for the 4 of this product’s 6 NDCs it lists (“1 VIAL, SINGLE-DOSE in 1 CARTON (0409-9094-55) / 50 mL in 1 VIAL, SINGLE-DOSE (0409-9094-44)”), so the card starts at one package: 50 ML. Change it to match your prescription.